Montefiore Einstein Comprehensive Cancer Center opens center for breast cancer care

Weight-associated breast cancer risk is higher in women with cardiovascular disease, IARC analysis shows

Excess weight is linked to an especially high risk of developing breast cancer in postmenopausal women with cardiovascular disease, according to research from the International Agency for Research on Cancer. The study was published in Cancer.

July 11, 2025

Vol.51 No.27

Clinical Roundup

Scientists uncover new approach for targeting aggressive breast cancer

A recent study from cancer researchers at the University of Alabama at Birmingham and Georgia State University has identified a new therapeutic target in quadruple-negative breast cancer, or QNBC, one of the deadliest and most aggressive treatment-resistant forms of breast cancer.

July 03, 2025

Vol.51 No.26

In Brief

UNC Lineberger awarded up to $28M from ARPA-H to develop clinical trial for metastatic breast cancer

UNC Lineberger Comprehensive Cancer Center has been awarded up to $28 million by the Advanced Research Projects Agency for Health to lead the development of a next-generation clinical trial for breast cancer that has spread to other parts of the body.

June 20, 2025

Vol.51 No.24

Drugs & Targets

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

Clairity Inc. received FDA De Novo authorization for CLAIRITY BREAST, a novel, image-based prognostic platform designed to predict five-year breast cancer risk from a routine screening mammogram. With this authorization, Clairity is planning to launch among leading health systems through 2025—propelling a new era of precision medicine in breast cancer.

June 06, 2025

Vol.51 No.22

Drugs & Targets

China’s NMPA approves zanidatamab in China for previously treated, unresectable or metastatic HER2+ biliary tract cancer

The National Medical Products Administration in China approved zanidatamab for the treatment of patients with previously treated, unresectable or metastatic HER2-positive biliary tract cancer.

June 06, 2025

Vol.51 No.22

Pfizer seeks to improve breast cancer outcomes in Sub-Saharan Africa
With help from Conquer Cancer’s EveryGrant and ASCO’s Sub-Saharan Africa Regional Council, Pfizer awards grants to seven countries

Pfizer External Research & Grants’ “Improving Breast Cancer Quality of Care via Meaningful Capacity Building in Sub-Saharan Africa,” powered by EveryGrant, has announced grants totaling more than $900,000 for addressing inequities and improving the quality of breast cancer care in Sub-Saharan Africa.

May 30, 2025

Vol.51 No.21

By Claire Marie Porter

Montefiore Einstein Comprehensive Cancer Center opens center for breast cancer care

YOU MAY BE INTERESTED IN

Weight-associated breast cancer risk is higher in women with cardiovascular disease, IARC analysis shows

Scientists uncover new approach for targeting aggressive breast cancer

UNC Lineberger awarded up to $28M from ARPA-H to develop clinical trial for metastatic breast cancer

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

China’s NMPA approves zanidatamab in China for previously treated, unresectable or metastatic HER2+ biliary tract cancer

Pfizer seeks to improve breast cancer outcomes in Sub-Saharan Africa
With help from Conquer Cancer’s EveryGrant and ASCO’s Sub-Saharan Africa Regional Council, Pfizer awards grants to seven countries

Renew today!

Subscriber content

Never miss an issue!

Login

Montefiore Einstein Comprehensive Cancer Center opens center for breast cancer care

YOU MAY BE INTERESTED IN

Weight-associated breast cancer risk is higher in women with cardiovascular disease, IARC analysis shows

Scientists uncover new approach for targeting aggressive breast cancer

UNC Lineberger awarded up to $28M from ARPA-H to develop clinical trial for metastatic breast cancer

Clairity becomes the first FDA-authorized AI platform for breast cancer prediction

China’s NMPA approves zanidatamab in China for previously treated, unresectable or metastatic HER2+ biliary tract cancer

Pfizer seeks to improve breast cancer outcomes in Sub-Saharan AfricaWith help from Conquer Cancer’s EveryGrant and ASCO’s Sub-Saharan Africa Regional Council, Pfizer awards grants to seven countries

Never miss an issue!

Login

Pfizer seeks to improve breast cancer outcomes in Sub-Saharan Africa
With help from Conquer Cancer’s EveryGrant and ASCO’s Sub-Saharan Africa Regional Council, Pfizer awards grants to seven countries